![](/img/cover-not-exists.png)
Reversion from chronic migraine to episodic migraine following treatment with erenumab: Results of a post-hoc analysis of a randomized, 12-week, double-blind study and a 52-week, open-label extension
Lipton, Richard B, Tepper, Stewart J, Silberstein, Stephen D, Kudrow, David, Ashina, Messoud, Reuter, Uwe, Dodick, David W, Zhang, Feng, Rippon, Gregory A, Cheng, Sunfa, Mikol, Daniel DJournal:
Cephalalgia
DOI:
10.1177/0333102420973994
Date:
December, 2020
File:
PDF, 406 KB
2020